Zhiguo Lin
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Genetics top 5%
- Glioma Diagnosis and Treatment
Papers in
-
- Circular RNAs in diseases 5
- RNA Research and Splicing 4
-
- MicroRNA in disease regulation 12
- Cancer-related molecular mechanisms research 7
- Co-authors
- Hong Shen (19 shared papers)Minwei Zhu (12 shared papers)Na Meng (14 shared papers)Zhenfeng Jiang (12 shared papers)Anhua Wu (6 shared papers)Cunyi Zou (5 shared papers)Gefei Guan (5 shared papers)Shuai Shen (4 shared papers)
- Journals
- Neuro-Oncology (4 papers)Epilepsy Research (3 papers)Academic Radiology (2 papers)Frontiers in Immunology (2 papers)Clinical Rheumatology (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Zhiguo Lin
67 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 104
- Cancer Research 368
- Genetics 193
- Immunology 240
- Neurology 84
- Psychiatry and Mental health 132
Countries citing papers authored by Zhiguo Lin
This map shows the geographic impact of Zhiguo Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhiguo Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhiguo Lin more than expected).
Fields of papers citing papers by Zhiguo Lin
This network shows the impact of papers produced by Zhiguo Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhiguo Lin. The network helps show where Zhiguo Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhiguo Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Ferroptosis, as the most enriched programmed cell death process in glioma, induces immunosuppression and immunotherapy resistance Hit paper breakdown → | 2022 | 153 |
| 2 | 2018 | 62 | |
| 3 | 2015 | 60 | |
| 4 | 2017 | 45 | |
| 5 | 2014 | 41 | |
| 6 | 2017 | 41 | |
| 7 | 2014 | 36 | |
| 8 | 2017 | 36 | |
| 9 | 2022 | 33 | |
| 10 | 2016 | 32 | |
| 11 | 2009 | 31 | |
| 12 | 2017 | 31 | |
| 13 | 2019 | 31 | |
| 14 | 2018 | 29 | |
| 15 | 2013 | 26 | |
| 16 | 2019 | 26 | |
| 17 | 2015 | 24 | |
| 18 | 2015 | 23 | |
| 19 | 2017 | 22 | |
| 20 | 2024 | 22 |
About Zhiguo Lin
Zhiguo Lin is a scholar working on Molecular Biology, Cancer Research, Genetics, Cellular and Molecular Neuroscience and Pulmonary and Respiratory Medicine, having authored 71 papers that have together received 1.3k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (12 papers), MicroRNA in disease regulation (12 papers), Ferroptosis and cancer prognosis (9 papers), Neuroscience and Neuropharmacology Research (7 papers), Cancer-related molecular mechanisms research (7 papers), Circular RNAs in diseases (5 papers), Advanced Neuroimaging Techniques and Applications (5 papers) and RNA Research and Splicing (4 papers). The work is most often cited by research in Cancer Research (368 citations), Genetics (193 citations), Immunology (240 citations), Neurology (84 citations) and Psychiatry and Mental health (132 citations). Zhiguo Lin has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Hong Shen, Minwei Zhu, Na Meng, Zhenfeng Jiang, Anhua Wu, Cunyi Zou, Gefei Guan, Shuai Shen, Tianqi Liu and Peng Cheng. Their work appears in journals such as Neuro-Oncology, Epilepsy Research, Academic Radiology, Frontiers in Immunology and Clinical Rheumatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.